期刊文献+

多药耐药阴沟肠杆菌临床株ampC基因的克隆和表达 被引量:5

Cloning and expression of ampC gene from a multidrug resistant isolate of Enterobacter cloacae
下载PDF
导出
摘要 目的克隆一株临床分离的多药耐药阴沟肠杆菌的ampC基因,并研究其编码的AmpCβ-内酰胺酶的特性。方法聚合酶链反应(PCR)扩增阴沟肠杆菌ECLC074的ampC基因,将扩增的目标片段连接入pMD18-T进行双链测序后,进一步克隆入pACYC184质粒,用获得的pACYC184/ampC重组质粒转化大肠杆菌MC4100。采用琼脂稀释法测定阴沟肠杆菌ECLC074,大肠杆菌MC4100及大肠杆菌MC4100重组菌的抗生素敏感性,采用三维试验及等电聚焦电泳研究β-内酰胺酶的特性。结果DNA测序及限制性酶切分析结果表明,阴沟肠杆菌ECLC074的ampC基因已被克隆入pACYC184质粒,大肠杆菌MC4100重组菌和阴沟肠杆菌ECLC074均产生一种等电点为7.8的β-内酰胺酶,该酶具有AmpCβ-内酰胺酶的耐药表型特征。结论阴沟肠杆菌的ampC基因可以被克隆入pACYC184质粒,并能在大肠杆菌MC4100中表达,这为深入研究染色体AmpCβ-内酰胺酶创造了条件。 Objectives To clone the ampC gene from a multidrug resistant isolate of Enterobacter cloacae and identify the properties of the ampC β-lactamase encoded by the cloned gene. Methods The entire ampC gene of Enterobacter cloacae ECLC074 was amplified by polymerase chain reaction. The target amplification fragment was ligated with pMD18-T to be sequenced on both strands by the dideoxy chain termination method. The ampC gene was then cloned into plasmid pACYC184. The recombinant plasmid pACYC184/ampC was transformed into E. coli MC4100. Agar dilution susceptibility test was used to determine the antibiotics susceptibilitiy of Enterobacter cloacae ECLC074, E. coli MC4100 and the recombinant E. coli MC4100 strain. Three-dimensional extract test, and analytical isoelectric focusing overlay technique were used to identify the properties of β-lactamases, Results Sequencing and restriction analysis revealed that ampC gene of Enterobacter cloacae ECLC074 was cloned into pACYC184 plasmid. Both Enterobacter cloacae ECLC074 and the recombinant E. coli MC4100 strain produced a β-lactamase with an isoelectric point of 7.8 and a drug-resistant phenotype characteristic of an ampC β-lactamase. Conclusion ampC gene of Enterobacter cloacae can be cloned into pACYC184 plasmid and expressed in E. coli MC4100, this forms the basis for further study of chromosomal ampC β-lactamases.
出处 《中华老年多器官疾病杂志》 2007年第5期329-333,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 肠杆菌 阴沟 Β-内酰胺酶类 克隆 基因 Enterobacter cloacae β-lactamases, cloning gene
  • 相关文献

参考文献10

  • 1[1]Rice LB,Bonomo RA.Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents.In:Lorian V,ed.Antibiotics in laboratory medicine.5th ed.Philadelphia:Williams & Wilkins,2005.441-509.
  • 2佘丹阳,刘又宁.AmpC酶和超广谱β-内酰胺酶在阴沟肠杆菌中的表达及对其耐药性的影响[J].中华医学杂志,2002,82(19):1355-1358. 被引量:86
  • 3[3]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing;12th informational supplement(M100-S12).Wayne:NCCLS,2002.
  • 4[4]Coudron PE,Moland ES,Thomson KS.Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center.J Clin Microbiol,2000,38:1791-1796.
  • 5[5]Hidri N,Barnaud G,Decre D,et al.Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the ampC beta-lactamase of a Serratia marcescens clinical isolate.J Antimicrob Chemother,2005,55:496-499.
  • 6[6]Mammeri H,Nazic H,Naas T,et al.ampC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.Antimicrob Agents Chemother,2004,48:4050-4053.
  • 7[7]Mammeri H,Poirel L,Bemer P,et al.Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded ampC beta-lactamase of a Serratia marcescens clinical isolate.Antimicrob Agents Chemother,2004,48:716-720.
  • 8[8]Barnaud G,Benzerara Y,Gravisse J,et al.Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.Antimicrob Agents Chemother,2004,48:1040-1042.
  • 9[9]Barnaud G,Labia R,Raskine L,et al.Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.FEMS Microbiol Lett,2001,195:185-190.
  • 10[10]Raimondi A,Sisto F,Nikaido H.Mutation in Serratia marcescens ampC β-lactamase producing high-level resistance to ceftazidime and cefpirome.Antimicrob Agents Chemother,2001,45:2331-2339.

二级参考文献9

  • 1Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, eds. Antibiotics in laboratory medicine. 4th ed. Baltimore:Williams & Wilkins, 1996. 502-578.
  • 2Sanders CC. β-lactamase of gram negative bacteria: new challenges for new drugs. Clin Infect Dis, 1992,14:1089-1099.
  • 3Naumiuk L, Samet A, Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase(ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother, 2001,48:321-322.
  • 4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement(M100-S9). Wayne:NCCLS,1999.
  • 5Coudron PE,Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000, 38:1791-1796.
  • 6Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol, 2000,38:542-546.
  • 7Chanal C, Sirot D, Romaszko JP, et al. Survey of extended-spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother, 1996, 38:127-132.
  • 8Coudron PE,Moland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol, 1997, 35:2593-2597.
  • 9王辉,吴伟元,陈民钧.肠杆菌科细菌中超广谱β-内酰胺酶(ESBL)的研究[J].中华微生物学和免疫学杂志,2001,21(6):676-679. 被引量:100

共引文献85

同被引文献50

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部